← Leaderboards
Mark M Moasser
University Of California San Francisco
$4,612,425
Attributed
$4,612,425
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $768.2K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,612,425 · 3
By mechanism
R01$4,273,575 · 2
R21$338,850 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Christine A. Miaskowski$35,237,360
- Robert Charles Brasch$2,930,908
- S John Mihic$5,253,471
- Rebecca Smith-Bindman$20,783,400
- Carolyn R Bertozzi$44,381,955
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseSignal TransductionTumorMalignant NeoplasmsPhosphorylationOncogenicMediatingModalityResponseIn VivoLinkAntibodiesSurfaceResistancePhosphotransferasesPharmaceutical PreparationsProgramsInhibitor/AntagonistOncogenesEpidermal Growth Factor ReceptorErbb2 GeneFamilyDrug ResistanceErbb3 Gene
Grant awards (17)
Understanding resistance in the HER2-HER3 tumor drive$298,554
R01 · FY2017 · CA · contact PI
Understanding resistance in the HER2-HER3 tumor drive$298,554
R01 · FY2016 · CA · contact PI
Understanding resistance in the HER2-HER3 tumor drive$298,554
R01 · FY2015 · CA · contact PI
Understanding resistance in the HER2-HER3 tumor drive$288,760
R01 · FY2014 · CA · contact PI
Understanding resistance in the HER2-HER3 tumor drive$295,885
R01 · FY2013 · CA · contact PI
Understanding resistance to HER family tyrosine kinase inhibitors$246,252
R01 · FY2011 · CA · contact PI
Understanding resistance to HER family tyrosine kinase inhibitors$253,936
R01 · FY2010 · CA · contact PI
Understanding resistance to HER family tyrosine kinase inhibitors$337,411
R01 · FY2009 · CA · contact PI
Adhesion signaling by a novel mitotic substrate of src$255,337
R01 · FY2009 · CA · contact PI
Understanding resistance to HER family tyrosine kinase inhibitors$327,722
R01 · FY2008 · CA · contact PI
Adhesion signaling by a novel mitotic substrate of src$255,337
R01 · FY2008 · CA · contact PI
Pilot studies to develop probes for in vivo imaging of P13K/Akt pathway activity$185,100
R21 · FY2008 · CA · contact PI
Understanding resistance to HER family tyrosine kinase inhibitors$329,682
R01 · FY2007 · CA · contact PI
Adhesion signaling by a novel mitotic substrate of src$255,337
R01 · FY2007 · CA · contact PI
Pilot studies to develop probes for in vivo imaging of P13K/Akt pathway activity$153,750
R21 · FY2007 · CA · contact PI
Adhesion signaling by a novel mitotic substrate of src$262,963
R01 · FY2006 · CA · contact PI
Adhesion signaling by a novel mitotic substrate of src$269,291
R01 · FY2005 · CA